Ardent Health (NYSE:ARDT) Releases Earnings Results, Beats Estimates By $0.08 EPS

Ardent Health (NYSE:ARDT – Get Free Report) issued its earnings results on Wednesday. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08, FiscalAI reports. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%. The company had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.60 billion.

Ardent Health Stock Up 10.7%

NYSE ARDT traded up $1.26 on Wednesday, reaching $12.97. The company had a trading volume of 1,076,331 shares, compared to its average volume of 454,994. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61. The company’s fifty day moving average is $11.19 and its 200 day moving average is $10.00. Ardent Health has a 52-week low of $7.71 and a 52-week high of $14.82. The stock has a market capitalization of $1.83 billion, a P/E ratio of 23.57, a P/E/G ratio of 3.32 and a beta of 0.58.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Truist Financial upped their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Leerink Partners reissued an “outperform” rating and set a $14.00 target price on shares of Ardent Health in a research report on Friday, September 18th. The Goldman Sachs Group reissued a “neutral” rating and set a $13.00 target price on shares of Ardent Health in a research report on Thursday, August 6th. Weiss Ratings upgraded shares of Ardent Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, October 6th. Finally, Guggenheim upped their target price on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $12.79.

View Our Latest Report on Ardent Health

Ardent Health Company Profile

(Get Free Report)

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.

See Also

Earnings History for Ardent Health (NYSE:ARDT)

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.